Nakajima Madoka, Miyajima Masakazu, Ogino Ikuko, Sugano Hidenori, Akiba Chihiro, Domon Naoko, Karagiozov Kostadin L, Arai Hajime
Department of Neurosurgery, Juntendo University School of Medicine, Tokyo, Japan.
Department of Neurosurgery, Juntendo University School of Medicine, Tokyo, Japan.
World Neurosurg. 2015 Mar;83(3):387-93. doi: 10.1016/j.wneu.2014.08.004. Epub 2014 Aug 7.
In Japan, idiopathic normal pressure hydrocephalus (iNPH) currently is treated mainly with lumboperitoneal (LP) shunts. Our aim was to evaluate whether LP shunting via the use of Medtronic Strata NSC programmable valves was as effective as ventriculoperitoneal shunting in the treatment of patients with iNPH from the perspectives of safety and symptomatic improvement rate.
The clinical records of 51 iNPH patients (mean age, 75 years; males, 29), who underwent placement of Medtronic Strata NSC LP shunt systems were reviewed retrospectively as a cohort. LP shunting was evaluated with the modified Rankin Scale, the Japan Normal-Pressure Hydrocephalus Grading Scale, the Mini-Mental State Examination, the Frontal Assessment Battery, and the Trail-Making Test A as outcome measures.
Modified Rankin Scale scores improved from 3.2 to 2.2 (P < 0.01), indicating a 64% response rate 12 months after treatment. Total Japan Normal-Pressure Hydrocephalus Grading Scale scores decreased from 6.5 to 4.0 (P < 0.01), indicating a response rate of 81%. Mini-Mental State Examination scores improved from 22.2 to 25.4 (P < 0.01), Frontal Assessment Battery scores improved from 11.7 to 13.4 (P < 0.05), and Trail-Making Test A scores improved from 122.3 to 112.7 (P = 0.60). During the 12-month follow-up period, complications requiring surgery were observed in 6 cases (11.8%).
LP shunts showed effectiveness rates that were similar to those of ventriculoperitoneal shunts. Despite the relatively high complication rate, LP shunts can be recommended for the treatment of patients with iNPH because of their minimal invasiveness and lack of lethal complications.
在日本,特发性正常压力脑积水(iNPH)目前主要采用腰大池-腹腔(LP)分流术治疗。我们的目的是从安全性和症状改善率的角度评估使用美敦力Strata NSC可编程阀门进行LP分流术在治疗iNPH患者方面是否与脑室-腹腔分流术同样有效。
回顾性分析51例接受美敦力Strata NSC LP分流系统植入的iNPH患者(平均年龄75岁;男性29例)的临床记录作为一个队列。以改良Rankin量表、日本正常压力脑积水分级量表、简易精神状态检查表、额叶评估量表和连线测验A作为评估LP分流术的结果指标。
改良Rankin量表评分从3.2改善至2.2(P<0.01),表明治疗12个月后的有效率为64%。日本正常压力脑积水分级量表总分从6.5降至4.0(P<0.01),表明有效率为81%。简易精神状态检查表评分从22.2提高至25.4(P<0.01),额叶评估量表评分从11.7提高至13.4(P<0.05),连线测验A评分从122.3降至112.7(P=0.60)。在12个月的随访期内,6例(11.8%)出现需要手术处理的并发症。
LP分流术显示出与脑室-腹腔分流术相似的有效率。尽管并发症发生率相对较高,但由于LP分流术具有微创性且无致命并发症,因此可推荐用于治疗iNPH患者。